Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384948587> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4384948587 endingPage "24" @default.
- W4384948587 startingPage "24" @default.
- W4384948587 abstract "BACKGROUND: Breast reduction mammoplasty (BRM) is among the most commonly performed procedures in plastic surgery. Postoperative hematoma is one of the most common complications following BRM, with an incidence of 1-7% in the literature. Tranexamic acid (TXA) has been shown to reduce perioperative bleeding and need for transfusion when administered intravenously or topically. However, TXA remains underutilized in plastic surgery, and there is a paucity of adequately powered, randomized studies of its efficacy. The authors sought to investigate whether topical administration of TXA reduces postoperative bleeding and hematoma following reduction mammoplasty. METHODS: This was a double-blinded, randomized controlled trial of 98 patients (196 breasts) undergoing bilateral primary reduction mammoplasty at a single academic institution. One breast was randomized to receive 1000mg of topical TXA before closure, and the other received a placebo (saline). The surgical team and the patient were blinded to which breast received the study drug. Drains were used in all patients. Incidence of hematoma within 30 days of surgery was recorded, as well as drain outputs, duration of drain use, and postoperative complications including seroma, wound healing issues, and infection. RESULTS: The overall hematoma rate was 1.5%. Two breasts that received TXA developed a hematoma, and one hematoma occurred in a breast that received the placebo. There was no significant difference in drain output from TXA-treated breasts compared to controls (37.7cc versus 42.2cc, p=0.467). The hematoma rate of patients enrolled in the trial was similar to the overall rate of hematoma during the study time period (1.5% versus 2.4%, p=0.511). No adverse effects or thromboembolic events related to TXA were observed. There were no significant differences in postoperative complications. CONCLUSION: Topical application of TXA does not appear to decrease the incidence of hematoma following reduction mammoplasty." @default.
- W4384948587 created "2023-07-22" @default.
- W4384948587 creator A5023175066 @default.
- W4384948587 creator A5028888630 @default.
- W4384948587 creator A5039243728 @default.
- W4384948587 creator A5051348625 @default.
- W4384948587 creator A5054819283 @default.
- W4384948587 creator A5071043711 @default.
- W4384948587 creator A5071426418 @default.
- W4384948587 creator A5075792214 @default.
- W4384948587 creator A5086529957 @default.
- W4384948587 date "2023-05-01" @default.
- W4384948587 modified "2023-10-17" @default.
- W4384948587 title "37. Topical Tranexamic Acid Does Not Reduce the Incidence of Hematoma in Reduction Mammoplasty: A Double-blinded, Randomized Placebo-controlled Trial" @default.
- W4384948587 doi "https://doi.org/10.1097/01.gox.0000937744.24824.d2" @default.
- W4384948587 hasPublicationYear "2023" @default.
- W4384948587 type Work @default.
- W4384948587 citedByCount "0" @default.
- W4384948587 crossrefType "journal-article" @default.
- W4384948587 hasAuthorship W4384948587A5023175066 @default.
- W4384948587 hasAuthorship W4384948587A5028888630 @default.
- W4384948587 hasAuthorship W4384948587A5039243728 @default.
- W4384948587 hasAuthorship W4384948587A5051348625 @default.
- W4384948587 hasAuthorship W4384948587A5054819283 @default.
- W4384948587 hasAuthorship W4384948587A5071043711 @default.
- W4384948587 hasAuthorship W4384948587A5071426418 @default.
- W4384948587 hasAuthorship W4384948587A5075792214 @default.
- W4384948587 hasAuthorship W4384948587A5086529957 @default.
- W4384948587 hasBestOaLocation W43849485871 @default.
- W4384948587 hasConcept C121608353 @default.
- W4384948587 hasConcept C126322002 @default.
- W4384948587 hasConcept C137762411 @default.
- W4384948587 hasConcept C141071460 @default.
- W4384948587 hasConcept C142724271 @default.
- W4384948587 hasConcept C168563851 @default.
- W4384948587 hasConcept C204787440 @default.
- W4384948587 hasConcept C27081682 @default.
- W4384948587 hasConcept C2778579461 @default.
- W4384948587 hasConcept C2779409168 @default.
- W4384948587 hasConcept C2779637338 @default.
- W4384948587 hasConcept C2779662492 @default.
- W4384948587 hasConcept C2910018596 @default.
- W4384948587 hasConcept C2991743468 @default.
- W4384948587 hasConcept C31174226 @default.
- W4384948587 hasConcept C42219234 @default.
- W4384948587 hasConcept C530470458 @default.
- W4384948587 hasConcept C71924100 @default.
- W4384948587 hasConcept C81182388 @default.
- W4384948587 hasConceptScore W4384948587C121608353 @default.
- W4384948587 hasConceptScore W4384948587C126322002 @default.
- W4384948587 hasConceptScore W4384948587C137762411 @default.
- W4384948587 hasConceptScore W4384948587C141071460 @default.
- W4384948587 hasConceptScore W4384948587C142724271 @default.
- W4384948587 hasConceptScore W4384948587C168563851 @default.
- W4384948587 hasConceptScore W4384948587C204787440 @default.
- W4384948587 hasConceptScore W4384948587C27081682 @default.
- W4384948587 hasConceptScore W4384948587C2778579461 @default.
- W4384948587 hasConceptScore W4384948587C2779409168 @default.
- W4384948587 hasConceptScore W4384948587C2779637338 @default.
- W4384948587 hasConceptScore W4384948587C2779662492 @default.
- W4384948587 hasConceptScore W4384948587C2910018596 @default.
- W4384948587 hasConceptScore W4384948587C2991743468 @default.
- W4384948587 hasConceptScore W4384948587C31174226 @default.
- W4384948587 hasConceptScore W4384948587C42219234 @default.
- W4384948587 hasConceptScore W4384948587C530470458 @default.
- W4384948587 hasConceptScore W4384948587C71924100 @default.
- W4384948587 hasConceptScore W4384948587C81182388 @default.
- W4384948587 hasIssue "5S" @default.
- W4384948587 hasLocation W43849485871 @default.
- W4384948587 hasOpenAccess W4384948587 @default.
- W4384948587 hasPrimaryLocation W43849485871 @default.
- W4384948587 hasRelatedWork W1986537722 @default.
- W4384948587 hasRelatedWork W2032705424 @default.
- W4384948587 hasRelatedWork W2054810212 @default.
- W4384948587 hasRelatedWork W2064428643 @default.
- W4384948587 hasRelatedWork W2067511843 @default.
- W4384948587 hasRelatedWork W4229052534 @default.
- W4384948587 hasRelatedWork W4318930731 @default.
- W4384948587 hasRelatedWork W4360985058 @default.
- W4384948587 hasRelatedWork W4383216971 @default.
- W4384948587 hasRelatedWork W1907204785 @default.
- W4384948587 hasVolume "11" @default.
- W4384948587 isParatext "false" @default.
- W4384948587 isRetracted "false" @default.
- W4384948587 workType "article" @default.